Results 111 to 120 of about 5,159 (158)

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source

Early Initiation of Evolocumab in Patients With Acute Coronary Syndrome. [PDF]

Korean Circ J
Kim HL.
europepmc   +1 more source

VESALIUS keeps revolutionizing medicine: the case of evolocumab in primary prevention. [PDF]

Eur Heart J Cardiovasc Pharmacother
Galli M, Sciarretta S, Crea F.
europepmc   +1 more source

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis.

JAMA Netw Open
Kellogg C, Badillo Goicoechea E, Kim DD, Yaghi S, Chaturvedi S, Mehendale R, Orjuela K, Kass-Hout T, Morsi RZ, Morales J, Singh E, Jhaveri A, Prabhakaran S, Smith MM, Brorson JR, Golani S, Mazuera S, Kang R, Eltatawy A, Pillajo J, Siegler JE.   +20 more
europepmc   +1 more source

Effects of evolocumab combined with statin therapy on blood lipids, inflammatory factors, and endothelial function in patients with coronary heart disease. [PDF]

BMC Cardiovasc Disord
Jin X, Zhang M, Li C, Zhang J, Liang D.
europepmc   +1 more source

Evolocumab-induced allergic reaction in a post-partial gastrectomy patient: A case report. [PDF]

Medicine (Baltimore)
Hong X, Jiang X, Xu X, Xiong F, Huang X.
europepmc   +1 more source

Statin Intolerance, Evolocumab for Hyperlipidemia, and Arrhythmia: Lessons Learnt From a Challenging Clinical Scenario. [PDF]

Cureus
Balocco MM, Uddin R, Dimeo SP, Falluji N, Waheed A.   +4 more
europepmc   +1 more source

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries. [PDF]

Cost Eff Resour Alloc
Azari S, Pourasghari H, Rezaei MA, Behzadifar M, Salehbeigi S, Rajaei S, Jafarzadeh D, Soleimanpour S, Tajdini M.   +8 more
europepmc   +1 more source

Clinical and genetic characterization of homozygous <i>LDLR</i> variants in familial hypercholesterolaemia: insights from two case reports. [PDF]

Eur Heart J Case Rep
Sahoo SK, Singh PK, Barik R, Prakash S, Sahoo D, Mohanty CR, Malla SR, Mohapatra RK.   +7 more
europepmc   +1 more source

Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors. [PDF]

Front Med (Lausanne)
Zhu B, Shao Q, Cui J, Fu Z, Ma Y.
europepmc   +1 more source